JSM2025
Back to all people

Ann Marie Weideman

Eli Lilly and Company
2 appearances in the program

Sessions & presentations

Advancing Late Phase Trials: Embracing Innovative Design and Analysis Strategies
Presentation: Preservation of Type I error for partially-unblinded sample size re-estimation
Contributed Papers · Tue, Aug 5 , 2:00 PM
First Author
Advancing Late Phase Trials: Embracing Innovative Design and Analysis Strategies
Presentation: Preservation of Type I error for partially-unblinded sample size re-estimation
Contributed Papers · Tue, Aug 5 , 2:00 PM
Presenting Author